Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.

Konstantinides S, Schäfer K, Thinnes T, Loskutoff DJ.

Circulation. 2001 Jan 30;103(4):576-83.

2.

Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.

Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D.

Blood. 2000 Jan 15;95(2):577-80.

3.

Vitronectin inhibits the thrombotic response to arterial injury in mice.

Fay WP, Parker AC, Ansari MN, Zheng X, Ginsburg D.

Blood. 1999 Mar 15;93(6):1825-30.

4.

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.

Zhu Y, Carmeliet P, Fay WP.

Circulation. 1999 Jun 15;99(23):3050-5.

5.

Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.

Peng L, Bhatia N, Parker AC, Zhu Y, Fay WP.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):934-9.

7.

Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.

de Waard V, Arkenbout EK, Carmeliet P, Lindner V, Pannekoek H.

Arterioscler Thromb Vasc Biol. 2002 Dec 1;22(12):1978-83.

8.

Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.

Schafer K, Müller K, Hecke A, Mounier E, Goebel J, Loskutoff DJ, Konstantinides S.

Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2097-103. Epub 2003 Sep 25.

9.
10.

Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin.

Koschnick S, Konstantinides S, Schäfer K, Crain K, Loskutoff DJ.

J Thromb Haemost. 2005 Oct;3(10):2290-5.

11.

Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.

Schäfer K, Schroeter MR, Dellas C, Puls M, Nitsche M, Weiss E, Hasenfuss G, Konstantinides SV.

Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1254-9. Epub 2006 Mar 2.

12.

Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.

Kawasaki T, Dewerchin M, Lijnen HR, Vermylen J, Hoylaerts MF.

Blood. 2000 Jul 1;96(1):153-60.

13.

Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.

Schäfer K, Konstantinides S, Riedel C, Thinnes T, Müller K, Dellas C, Hasenfuss G, Loskutoff DJ.

Circulation. 2002 Oct 1;106(14):1847-52.

14.

Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.

Reheman A, Gross P, Yang H, Chen P, Allen D, Leytin V, Freedman J, Ni H.

J Thromb Haemost. 2005 May;3(5):875-83. Epub 2005 Feb 23.

15.
16.

Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice.

Farrehi PM, Ozaki CK, Carmeliet P, Fay WP.

Circulation. 1998 Mar 17;97(10):1002-8.

17.

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.

Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, Gerard RD.

Circulation. 1997 Nov 4;96(9):3180-91.

19.

Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.

Podor TJ, Singh D, Chindemi P, Foulon DM, McKelvie R, Weitz JI, Austin R, Boudreau G, Davies R.

J Biol Chem. 2002 Mar 1;277(9):7529-39. Epub 2001 Dec 14.

20.

Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.

Matsuno H, Kozawa O, Niwa M, Ueshima S, Matsuo O, Collen D, Uematsu T.

Thromb Haemost. 1999 Apr;81(4):601-4.

PMID:
10235447

Supplemental Content

Support Center